ClinicalTrials.Veeva

Menu

Swiss Postpartum Hypertension Cohort

University Hospital Basel logo

University Hospital Basel

Status

Enrolling

Conditions

Postpartum Hypertension (PPHT)

Treatments

Other: Data collection on patient reported outcomes
Other: Data collection for blood pressure (BP)
Other: Home-based blood pressure management (substudy)
Other: Data collection for parameters of organ damage (cardiac and renal blood markers)
Other: Biomarker Profiles (substudy)

Study type

Observational

Funder types

Other

Identifiers

NCT04690660
2020-00736 me20Burkard;

Details and patient eligibility

About

This open label, prospective observational, single-center registry is to study short-, intermediate-and long-term course of postpartum hypertension and predictors/risk factors associated with long term cardiovascular and renal risk.

Current disease management strategies will be evaluated.

Enrollment

480 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all women with hypertensive disorders of pregnancy
  • postpartum hypertension (blood pressure measurements of systolic ≥140 and/or diastolic ≥ 90mmHg or antihypertensive therapy within the first 14 days after delivery)
  • women with preexisting hypertension or
  • women on antihypertensive medication

Exclusion criteria

  • delivery > 14 days
  • lack of consent to participate in the study, language barriers or lack of general understanding

Trial contacts and locations

1

Loading...

Central trial contact

Thilo Burkard, Dr. med.; Thenral Socrates, Dr. med.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems